Related Experiment Video
Updated: Aug 7, 2026
Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies
Published on: May 26, 2023
The Use of High-Throughput Transcriptomics to Identify Pathways with Therapeutic Significance in Podocytes
Ashish K Solanki1, Pankaj Srivastava1, Bushra Rahman1
1Department of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, SC 29425, USA.
Abstract:
Podocytes have a unique structure that supports glomerular filtration function, and many glomerular diseases result in loss of this structure, leading to podocyte dysfunction and ESRD (end stage renal disease). These structural and functional changes involve a complex set of molecular and cellular mechanisms that remain poorly understood. To understand the molecular signature of podocyte injury, we performed transcriptome analysis of cultured human podocytes injured either with PAN (puromycin aminonucleoside) or doxorubicin/adriamycin (ADR). The pathway analysis through DE (differential expression) and gene-enrichment analysis of the injured podocytes showed Tumor protein p53 (P53) as one of the major signaling pathways that was significantly upregulated upon podocyte injury. Accordingly, P53 expression was also up-regulated in the glomeruli of nephrotoxic serum (NTS) and ADR-injured mice. To further confirm these observations, cultured podocytes were treated with the P53 inhibitor pifithrin-α, which showed significant protection from ADR-induced actin cytoskeleton damage. In conclusion, signaling pathways that are involved in podocyte pathogenesis and can be therapeutically targeted were identified by high-throughput transcriptomic analysis of injured podocytes.
Insights
Tumor protein p53 (P53) signaling is upregulated in podocyte injury, a key factor in kidney disease progression. Inhibiting P53 protected podocytes from damage, suggesting a potential therapeutic target for glomerular diseases.
Area of Science:
- Nephrology
- Molecular Biology
- Genomics
Background:
- Podocyte structural integrity is crucial for glomerular filtration.
- Glomerular diseases often lead to podocyte injury, dysfunction, and end-stage renal disease (ESRD).
- The molecular mechanisms underlying podocyte injury are not fully understood.
Purpose of the Study:
- To identify molecular signatures of podocyte injury.
- To explore potential therapeutic targets for glomerular diseases.
Main Methods:
- Transcriptome analysis of cultured human podocytes exposed to puromycin aminonucleoside (PAN) or doxorubicin/adriamycin (ADR).
- Differential expression (DE) and gene-enrichment analysis.
- In vivo validation in nephrotoxic serum (NTS) and ADR-injured mouse models.
- Treatment with a P53 inhibitor (pifithrin-α) in cultured podocytes.
Main Results:
- Tumor protein p53 (P53) signaling pathway was significantly upregulated in injured podocytes.
- P53 expression was also elevated in the glomeruli of NTS and ADR-injured mice.
- P53 inhibition provided significant protection against ADR-induced actin cytoskeleton damage in podocytes.
Conclusions:
- High-throughput transcriptomic analysis identified key signaling pathways in podocyte injury.
- The P53 pathway is implicated in podocyte pathogenesis.
- Targeting P53 signaling may offer a therapeutic strategy for glomerular diseases.
